Cover Image
Market Research Report
Product code 
1062919

Oncology Biosimilars Global Market Report 2022

Published: Pre-Order | The Business Research Company | 300 Pages | Delivery time: 2-10 business days

Price

Back to Top
Oncology Biosimilars Global Market Report 2022
Published: Pre-Order
The Business Research Company
Content info: 300 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents

“Oncology Biosimilars Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology biosimilars market.

This report focuses on oncology biosimilars market which is experiencing strong growth. The report gives a guide to the oncology biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology biosimilars? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Oncology Biosimilars market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology biosimilars market section of the report gives context. It compares the oncology biosimilars market with other segments of the oncology biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology biosimilars indicators comparison.

Scope

Markets Covered:

1) By Drug Type: Monoclonal Antibody; Immunomodulators; Hematopoietic Agents; Granulocyte Colony-Stimulating Factor (G-CSF)

2) By Cancer Type: Breast Cancer; Colorectal Cancer; Blood Cancer; Neutropenia Cancer; Non-Small Cell Lung Cancer; Others

3) By Distribution Type: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Companies Mentioned: Biocoin; Celltrion Inc.; Dr. Reddy's Laboratories Ltd.; Intas Pharmaceuticals Ltd.; STADA Arzneimittel AG

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: h1141

Table of Contents

1. Executive Summary

2. Oncology Biosimilars Market Characteristics

3. Oncology Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Oncology Biosimilars

5. Oncology Biosimilars Market Size And Growth

  • 5.1. Global Oncology Biosimilars Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oncology Biosimilars Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oncology Biosimilars Market Segmentation

  • 6.1. Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Monoclonal Antibody
  • Immunomodulators
  • Hematopoietic Agents
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • 6.2. Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Breast Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Neutropenia Cancer
  • Non-Small Cell Lung Cancer
  • Others
  • 6.3. Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Oncology Biosimilars Market Regional And Country Analysis

  • 7.1. Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Oncology Biosimilars Market

  • 8.1. Asia-Pacific Oncology Biosimilars Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Oncology Biosimilars Market

  • 9.1. China Oncology Biosimilars Market Overview
  • 9.2. China Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Oncology Biosimilars Market

  • 10.1. India Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Oncology Biosimilars Market

  • 11.1. Japan Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Oncology Biosimilars Market

  • 12.1. Australia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Oncology Biosimilars Market

  • 13.1. Indonesia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Oncology Biosimilars Market

  • 14.1. South Korea Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Oncology Biosimilars Market

  • 15.1. Western Europe Oncology Biosimilars Market Overview
  • 15.2. Western Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Oncology Biosimilars Market

  • 16.1. UK Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Oncology Biosimilars Market

  • 17.1. Germany Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Oncology Biosimilars Market

  • 18.3. France Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Oncology Biosimilars Market

  • 19.1. Eastern Europe Oncology Biosimilars Market Overview
  • 19.2. Eastern Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Oncology Biosimilars Market

  • 20.1. Russia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Oncology Biosimilars Market

  • 21.1. North America Oncology Biosimilars Market Overview
  • 21.2. North America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Oncology Biosimilars Market

  • 22.1. USA Oncology Biosimilars Market Overview
  • 22.2. USA Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Oncology Biosimilars Market

  • 23.1. South America Oncology Biosimilars Market Overview
  • 23.2. South America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Oncology Biosimilars Market

  • 24.1. Brazil Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Oncology Biosimilars Market

  • 25.1. Middle East Oncology Biosimilars Market Overview
  • 25.2. Middle East Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Oncology Biosimilars Market

  • 26.1. Africa Oncology Biosimilars Market Overview
  • 26.2. Africa Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Oncology Biosimilars Market Competitive Landscape And Company Profiles

  • 27.1. Oncology Biosimilars Market Competitive Landscape
  • 27.2. Oncology Biosimilars Market Company Profiles
    • 27.2.1. Biocoin
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Celltrion Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Dr. Reddy's Laboratories Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Intas Pharmaceuticals Ltd.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. STADA Arzneimittel AG
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Oncology Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Oncology Biosimilars Market

30. Oncology Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer